COURSE
OF
CYSTIC
FIBROSIS
IN
95
PATIENTS
THE
COURSE
OF
95
PATIENTS
WITH
CYSTIC
FIBROSIS
IS
PRESENTED
SURVIVORS
HAVE
A
MEAN
FOLLOWUP
PERIOD
OF
OVER
14
YEARS
MINIMUM
13
YEARS
OF
45
PATIENTS
DIAGNOSED
PRIOR
TO
EXTENSIVE
IRREVERSIBLE
PULMONARY
INVOLVEMENT
ONLY
ONE
HAS
DIED
AND
NONE
IS
DISABLED
IN
CONTRAST
OF
THE
OTHER
50
PATIENTS
DIAGNOSED
AFTER
SUBSTANTIAL
IRREVERSIBLE
PULMONARY
DISEASE
WAS
PRESENT
26
HAVE
DIED
MORTALITY
AND
MORBIDITY
HAS
BEEN
GREATER
IN
FEMALES
POSSIBLE
FACTORS
CONTRIBUTING
TO
THE
IMPROVING
PROGNOSIS
INCLUDE
EARLY
DIAGNOSIS
AGGRESSIVE
MANAGEMENT
WITH
COMPREHENSIVE
CARE
EASY
ACCESS
TO
SPECIALIZED
CARE
AND
IMPROVED
ANTIMICROBIAL
THERAPY
